With a market cap of $19.1 billion, International Flavors & Fragrances Inc. (IFF) is a global leader in high-value ingredients and solutions across the food, beverage, scent, health, and pharmaceutical industries. Operating through four core segments - Nourish; Health & Biosciences; Scent; and Pharma Solutions, IFF delivers innovative, biotechnology-driven products to customers worldwide.
The New York-based company is expected to release its fiscal Q1 2025 earnings results after the market closes on Tuesday, May 6. Ahead of this event, analysts project IFF to report an adjusted EPS of $1.08, a decrease of 4.4% from $1.13 in the year-ago quarter. It has surpassed Wall Street's bottom-line estimates in three of the last four quarterly reports while missing on another occasion. In Q4 2024, IFF beat the consensus adjusted EPS estimate by a margin of 24.4%.
